Global Medical Stock Price, News & Analysis

Global Medical REIT (NYSE:GMRE) announced an underwritten public offering of its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share, subject to market conditions.

The company expects to grant underwriters a 30-day option for over-allotments, intends to use net proceeds for general corporate purposes including possible acquisitions and debt repayment, and plans to list the shares on the New York Stock Exchange under GMRE-PrB. Raymond James, BMO Capital Markets, Stifel and Baird are book-running managers. The offering is made under a shelf registration declared effective by the SEC on April 4, 2024.

Global Medical REIT (NYSE: GMRE) reported Q3 2025 results and corporate actions on November 4, 2025. Q3 net loss was $6.0M, or $0.45 per diluted share, driven primarily by a $6.3M impairment on an Aurora, IL facility that was sold. FFO rose to $14.5M ($1.00/share), and AFFO rose to $16.2M ($1.12/share), each up ~4% year-over-year on a per-share basis. Same-store cash NOI grew 2.7%. Portfolio occupancy was 95.2%; consolidated debt was $710M (leverage 47.3%) with a 4.06% weighted average interest rate. The company completed a one-for-five reverse split, established a $50M buyback program, and amended its credit facility to extend maturities and hedge term loan SOFR exposure.

Global Medical REIT (NYSE: GMRE) will release its third quarter 2025 financial results after market close on Tuesday, November 4, 2025.

The company will host a conference call and live webcast on Wednesday, November 5, 2025 at 9:00 a.m. Eastern Time, with President & CEO Mark Decker Jr., CFO Robert Kiernan, CIO Alfonzo Leon, and COO Danica Holley participating.

Investors may join via live webcast at https://investors.globalmedicalreit.com/news-events/ir-calendar (preferred). U.S. dial-in: 1-877-300-8521; international dial-in: 1-412-317-6026. A replay will be available from ~12:00 p.m. ET on Nov 5, 2025 through 11:59 p.m. ET on Nov 19, 2025 (replay dial-in: domestic 1-844-512-2921, international 1-412-317-6671, passcode 10203242).

Global Medical REIT (NYSE: GMRE) entered an amended and restated credit facility on October 8, 2025 that extends maturities and hedges interest-rate exposure.

Key changes: $400M revolver maturity extended to Oct 2029 with election to extend to Oct 2030; the existing $350M Term Loan A is split into A-1 $100M (Oct 2029), A-2 $100M (Oct 2030), and A-3 $150M (Apr 2031); the prior 0.10% SOFR spread adjustment was removed; and a $350M package of forward-starting interest-rate swaps was entered to hedge SOFR on the three Term Loan A tranches. Reported fixed swap bases are 3.24%–3.32% yielding effective rates of 4.75%–4.84% (inclusive of spreads). At close the weighted average debt term increased from 1.3 years to 4.4 years.

Global Medical REIT (NYSE:GMRE) has completed its previously announced one-for-five reverse stock split, effective September 19, 2025. The company's common stock will begin trading on a split-adjusted basis on the NYSE on September 22, 2025, maintaining its "GMRE" symbol but with a new CUSIP number: 37954A303.

The reverse split reduced GMRE's outstanding shares from 67,037,048 to approximately 13,407,409 and decreased authorized shares from 500,000,000 to 100,000,000. The company's stock repurchase program, equity incentive plan, and partnership units were proportionally adjusted. No fractional shares were issued, with affected stockholders receiving cash compensation based on the closing price.

Global Medical REIT (NYSE:GMRE) has declared its Q3 2025 dividends for both common and preferred stockholders. The company will pay a common dividend of $0.75 per share on October 15, 2025, to stockholders of record as of September 29, 2025. This dividend reflects the company's upcoming one-for-five reverse stock split, equivalent to $0.15 per share pre-split.

Additionally, GMRE declared a quarterly cash dividend of $0.46875 per share on its Series A Preferred Stock, payable on October 31, 2025, to preferred stockholders of record as of October 15, 2025, covering the period from July 31 through October 30, 2025.

Global Medical REIT (NYSE:GMRE) has announced two significant corporate actions: a $50 million common stock repurchase program and a one-for-five reverse stock split.

The stock repurchase program, approved on August 12, 2025, allows GMRE to purchase up to $50 million of its common stock through various methods, including open market and private transactions. The reverse stock split, effective September 19, 2025, will convert every five shares into one share, with trading on the split-adjusted basis beginning September 22, 2025. Fractional shares will be paid in cash based on the closing price at the effective time.

Global Medical REIT (NYSE:GMRE) reported its Q2 2025 financial results, highlighted by the appointment of Mark Decker, Jr. as CEO and the completion of a $69.6 million five-property medical portfolio acquisition. The company posted a net loss of $0.8 million ($0.01 per diluted share), while achieving AFFO of $16.6 million ($0.23 per share), up from $15.7 million in Q2 2024.

Key metrics include a 10.7% year-over-year increase in rental revenue to $37.9 million, portfolio occupancy of 94.5%, and total debt of $713.0 million with a 47.2% leverage ratio. The company maintained its full-year 2025 AFFO guidance of $0.89 to $0.93 per share and declared a quarterly dividend of $0.15 per share.

Global Medical REIT (NYSE:GMRE) has scheduled its second quarter 2025 financial results announcement for August 5, 2025, after market close. The company will host a conference call on August 6, 2025, at 9:00 a.m. Eastern Time, led by CEO Mark Decker, Jr., CFO Robert Kiernan, and CIO Alfonzo Leon.

Investors can access the call via webcast through GMRE's investor relations website or by dial-in. A replay will be available until August 20, 2025. GMRE operates as a net-lease medical REIT, focusing on acquiring and managing healthcare facilities leased to physician groups and healthcare systems.